Double-blind placebo-controlled administration of fluoxetine in restricting- and restricting-purging-type anorexia nervosa

American Psychiatric Association (1994): Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Press. Anderson, 1990, Dieting reduces plasma tryptophan and alters brain serotonin function in women, J Psychol Med, 20, 785, 10.1017/S0033291700036473 Attia, 1998, Does fluoxetine augment the inpatient treatment of anorexia nervosa?, Am J Psychiatry, 155, 548, 10.1176/ajp.155.4.548 Benfield, 1986, Fluoxetine, Drugs, 32, 481, 10.2165/00003495-198632060-00002 Biederman, 1985, Amitriptyline in the treatment of anorexia nervosa, J Clin Psychopharmacol, 5, 10, 10.1097/00004714-198502000-00003 Campbell, 1998, Lack of association between 5-HT2A promoter polymorphism and susceptibility to anorexia nervosa, Lancet, 351, 499, 10.1016/S0140-6736(05)78688-8 Channon, 1985, Psychological correlates of weight gain in patients with anorexia nervosa, J Psychiatr Res, 19, 267, 10.1016/0022-3956(85)90027-5 Collier, 1997, Association between 5-HT2A gene promoter polymorphism and anorexia nervosa, Lancet, 350, 412, 10.1016/S0140-6736(05)64135-9 Cox D, Oakes D (1984): Analysis of Survival Data. London: Chapman & Hall. Crisp, 1987, Clomipramine and “drive” in people with anorexia nervosa, Br J Psychiatry, 150, 355, 10.1192/bjp.150.3.355 Delgado, 1990, Serotonin function and the mechanism of antidepressant action, Arch Gen Psychiatry, 47, 411, 10.1001/archpsyc.1990.01810170011002 Eckert, 1982, Depression in anorexia nervosa, Psychol Med, 12, 115, 10.1017/S003329170004335X Enoch, 1998, Replication of an association between 5-HT2A promoter polymorphism −1438G/A and anorexia nervosa, and association with obsessive-compulsive disorder, Lancet, 351, 1785, 10.1016/S0140-6736(05)78746-8 Ferguson, 1999, Are SSRI’s effective in underweight anorexia nervosa?, Int J Eat Disord, 25, 11, 10.1002/(SICI)1098-108X(199901)25:1<11::AID-EAT2>3.0.CO;2-U Fink, 1996, Oestrogen and mental state, Nature, 383, 306, 10.1038/383306a0 Gibbons, 1979, Manipulations of dietary tryptophan, Brain Res, 169, 139, 10.1016/0006-8993(79)90380-9 Goodman, 1989, The Yale-Brown Obsessive Compulsive Scale (YBOCS), Arch Gen Psychiatry, 46, 1012, 10.1001/archpsyc.1989.01810110054008 Goodman, 1989, The Yale-Brown Obsessive Compulsive Scale (YBOCS), Arch Gen Psychiatry, 46, 1006, 10.1001/archpsyc.1989.01810110048007 Gowers, 1994, Outcome of outpatient psychotherapy in a random allocation treatment study of anorexia nervosa, Int J Eat Disord, 15, 165, 10.1002/1098-108X(199403)15:2<165::AID-EAT2260150208>3.0.CO;2-0 Gram, 1994, Fluoxetine, N Engl J Med, 331, 1354, 10.1056/NEJM199411173312008 Gwirtsman, 1990, Fluoxetine treatment of anorexia nervosa, J Clin Psychiatry, 51, 378 Hall, 1987, Brief psychotherapy in the treatment of anorexia nervosa, Br J Psychiatry, 151, 185, 10.1192/bjp.151.2.185 Halmi, 1986, anorexia nervosa, Arch Gen Psychiatry, 43, 177, 10.1001/archpsyc.1986.01800020087011 Hamilton, 1959, The assessment of anxiety states by rating, Br J Med Psychol, 32, 50, 10.1111/j.2044-8341.1959.tb00467.x Hamilton, 1960, A rating scale for depression, J Neurology Neurosurg Psychiatry, 23, 56, 10.1136/jnnp.23.1.56 Herzog, 1992, The current status of treatment for anorexia nervosa and bulimia nervosa, Int J Eat Disord, 12, 215, 10.1002/1098-108X(199209)12:2<215::AID-EAT2260120211>3.0.CO;2-Y Hinney, 1997, Serotonin transporter gene-linked polymorphic region, Life Sci, 61, 295, 10.1016/S0024-3205(97)00888-6 Hsu, 1988, The outcome of anorexia nervosa, Psychol Med, 18, 807, 10.1017/S0033291700009739 Hsu, 1980, Outcome of anorexia nervosa—a review of the literature (1954–1978), Arch Gen Psychiatry, 37, 1041, 10.1001/archpsyc.1980.01780220079009 Kalbfleisch J, Prentice R (1980): The Statistical Analysis of Failure Time Data. New York: Wiley. Kaye, 1984, Abnormalities in CNS monoamine metabolism in anorexia nervosa, Arch Gen Psychiatry, 41, 350, 10.1001/archpsyc.1984.01790150040007 Kaye, 1998, Alterations in serotonin activity and psychiatric symptomatology after recovery from bulimia nervosa, Arch Gen Psychiatry, 55, 927, 10.1001/archpsyc.55.10.927 Kaye, 1988, CSF 5-HIAA concentrations in anorexia nervosa, Biol Psychiatry, 23, 102, 10.1016/0006-3223(88)90113-8 Kaye, 1991, An open trial of fluoxetine in patients with anorexia nervosa, J Clin Psychiatry, 52, 464 Kendler, 1991, The genetic epidemiology of bulimia nervosa, Am J Psychiatry, 148, 1627, 10.1176/ajp.148.12.1627 Lacey JH, Crisp AH (1980): Hunger, food intake and weight: The impact of clomipramine on refeeding anorexia nervosa population. Postgrad Med J 56(suppl 1):79–85. Laessle, 1988, Depression as a correlate of starvation in patients with eating disorders, Biol Psychiatry, 23, 719, 10.1016/0006-3223(88)90056-X Lilenfeld, 1998, A controlled family study of anorexia and bulimia nervosa, Arch Gen Psychiatry, 55, 603, 10.1001/archpsyc.55.7.603 McKenzie, 1992, Hospitalization for anorexia nervosa, Int J Eat Disord, 11, 235, 10.1002/1098-108X(199204)11:3<235::AID-EAT2260110306>3.0.CO;2-T McQueen, 1996, Oestradiol-17 Beta increases serotonin transporter (SERT) binding sites and SERT mRNA expression in discrete regions of female rat brain, J Physiol (Lond), 495, 114 Messing, 1976, Interaction of diet and drugs in the regulation of brain 5-hydroxy indoles and the response to painful electric shock, Life Sci, 18, 707, 10.1016/0024-3205(76)90182-X Metropolitan Life Insurance Company (1959): New weight standards for men and women. Stat Bull Metrop Insur Co 40:1–11. Mitchell, 1993, A review of the controlled trials of pharmacotherapy and psychotherapy in the treatment of bulimia nervosa, Int J Eat Disord, 14, 229, 10.1002/1098-108X(199311)14:3<229::AID-EAT2260140302>3.0.CO;2-X Patton, 1988, Mortality in eating disorders, Psychol Med, 18, 947, 10.1017/S0033291700009879 Piccinelli, 1995, Efficacy of drug treatment in obsessive-compulsive disorder, Br J Psychiatry, 166, 424, 10.1192/bjp.166.4.424 Pollice, 1997, Relationship of depression, anxiety, and obsessionality to state of illness in anorexia nervosa, Int J Eat Disord, 21, 367, 10.1002/(SICI)1098-108X(1997)21:4<367::AID-EAT10>3.0.CO;2-W Russell, 1987, An evaluation of family therapy in anorexia nervosa and bulimia nervosa, Arch Gen Psychiatry, 44, 1047, 10.1001/archpsyc.1987.01800240021004 Schweiger, 1986, Effects of carbohydrate and protein meals on plasma large neutral amino acids, glucose and insulin plasma levels of anorectic patients, Metabolism, 35, 938, 10.1016/0026-0495(86)90058-2 Sorbi, 1998, 5-HT2A promoter polymorphism in anorexia nervosa, Lancet, 351, 1785, 10.1016/S0140-6736(05)78745-6 Srinivasagam, 1995, Persistent perfectionism, symmetry, and exactness in anorexia nervosa after long-term recovery, Am J Psychiatry, 152, 1630, 10.1176/ajp.152.11.1630 Stonehill, 1977, Psychoneurotic characteristics of patients with anorexia nervosa before and after treatment and at 4–7 year follow-up, J Psychosom Res, 21, 189, 10.1016/0022-3999(77)90089-7 Strober, 1997, Does adjunctive fluoxetine influence the post-hospital course of restrictor-type anorexia nervosa? A 24-month prospective, longitudinal followup and comparison with historical controls, Psychopharmacol Bull, 33, 425 Strober M, Katz JL (1988): Depression in the eating disorders: A review and analysis of descriptive, family, and biological findings. In: Garner DM, Garfinkel PE, editors. Diagnostic Issues in Anorexia Nervosa and Bulimia Nervosa, Vol 2. New York: Brunner/Mazel, 80–111. Sullivan, 1995, Mortality in anorexia nervosa, Am J Psychiatry, 152, 1073, 10.1176/ajp.152.7.1073 Sunday, 1995, The Yale-Brown-Cornell Eating Disorder Scale, Int J Eat Disord, 18, 237, 10.1002/1098-108X(199511)18:3<237::AID-EAT2260180305>3.0.CO;2-1 Theander S (1983): Long-term prognosis of anorexia nervosa: A preliminary report. In: Darby PL, editor. Anorexia Nervosa: Recent Developments in Research. New York: A.R. Liss, pp 441–442. Thiel, 1995, Obsessive-compulsive disorder among patients with anorexia nervosa and bulimia nervosa, Am J Psychiatry, 152, 72, 10.1176/ajp.152.1.72 Tollefson GD (1995): Selective serotonin reuptake inhibitors. In: Schatzberg AF, Memeroff CB, editors. Textbook of Psychopharmacology. Washington, DC: American Psychiatric Press, pp 161–182. Treasure, 1995, A pilot study of a randomized trial of cognitive analytical therapy vs educational behavioral therapy for adult anorexia nervosa, Behav Res Ther, 33, 363, 10.1016/0005-7967(94)00070-Z Vandereycken, 1984, Neuroleptics in the short-term treatment of anorexia nervosa, Br J Psychiatry, 144, 288, 10.1192/bjp.144.3.288 Vandereycken, 1982, Pimozide combined with behavior therapy in the short-term treatment of anorexia nervosa, Acta Psychiatr Scand, 66, 445, 10.1111/j.1600-0447.1982.tb04501.x Walsh BT (1995): Pharmacotherapy of eating disorders. In: Brownell KD, Fairburn CG, editors. Eating Disorders and Obesity: A Comprehensive Handbook. New York: Guilford, pp 329–340. Winer BJ (1971): Statistical Principles in Experimental Design, 2nd ed. New York: McGraw Hill. Yates, 1990, 5-HT2 receptor changes in major depression, Biol Psychiatry, 27, 489, 10.1016/0006-3223(90)90440-D